Background: Chronic renal failure is accompanied with muscle dysfunction and myopathy, characterized by muscle weakness and increased fatigue. Myosin heavy chain (MHC) is the principal structural protein that controls the intrinsic contractile properties of striated muscle. Creatine is widely used as an ergogenic nutritional supplement in sportsmen. This study investigates the effect of creatine supplementation on MHC expression in the setting of uremic myopathy. Methods: Male Wistar rats were either sham operated or subtotally nephrectomized and received a control diet or creatine (2% w/w)-supplemented diet. After 4 weeks of treatment, serum creatinine, creatine, urea and creatinine clearances were determined. MHC isoforms were determined electrophoretically in the extensor digitorum longus and soleus muscles. Results: Creatinine clearances were lower in nephrectomized animals, but similar in creatine-supplemented and control diet animals. Nephrectomized animals had significantly higher MHC IIb and lower MHC IIx isoform expression in the extensor digitorum longus muscle compared to sham-operated animals. In the soleus muscle, MHC IIb expression was increased in nephrectomized animals. Creatine supplementation reversed the MHC transitions observed in uremia in the soleus muscle, but not in the extensor digitorum longus muscle. Conclusion: We observed altered expression of MHC isoforms in uremia. In uremic animals, fast MHC IIb isoforms were increased, whereas MHC I and IIx isoforms predominate in control animals. Dietary creatine supplementation reversed the altered MHC expression during uremia in slow-twitch, but not in fast-twitch muscles.

1.
Clyne N, Esbjörnsson M, Jansson E, Jogestrand T, Lins LE, Pehrsson SK: Effects of renal failure on skeletal muscle. Nephron 1993;63:395–399.
[PubMed]
2.
Ritz E, Schoemig M, Massry SG: Uremic myopathy; in Massry S, Glassock R (eds): Textbook of Nephrology. Philadelphia, William & Wilkins, 2001, pp 1426–1429.
3.
Campistol JM: Uremic myopathy. Kidney Int 2002;62:1901–1913.
[PubMed]
4.
Mitch WE: Insights into the abnormalities of chronic renal disease attributed to malnutrition. J Am Soc Nephrol 2002;13:S22–S27.
5.
Schiaffino S, Reggiani C: Molecular diversity of myofibrillar proteins: Gene regulation and functional significance. Physiol Rev 1996;76:371–423.
[PubMed]
6.
Barrany M: ATPase activity of myosin correlated with speed of muscle shortening. J Gen Physiol 1967;50:197–218.
[PubMed]
7.
Baldwin KM, Haddad F: Effects of different activity and inactivity paradigms on myosin heavy chain gene expression in striated muscle. J Appl Physiol 2001;90:345–357.
[PubMed]
8.
Pette D, Staron RS: Cellular and molecular diversities of mammalian skeletal muscle fibers. Rev Physiol Biochem Pharmacol 1990;116:1–76.
[PubMed]
9.
Pette D: Historical perspectives: Plasticity of mammalian skeletal muscle. J Appl Physiol 2001;90:1119–1124.
[PubMed]
10.
Caiozzo VJ, Baker MJ, Baldwin KM: Novel transitions in MHC isoforms: Separate and combined effects of thyroid hormone and mechanical unloading. J Appl Physiol 1998;85:2237–2248.
[PubMed]
11.
Walker JB: Creatine: Biosynthesis, regulation and function. Adv Enzymol Relat Areas Mol Biol 1979;50:177–242.
[PubMed]
12.
Wyss M, Kaddurah Daouk R: Creatine and creatinine metabolism. Physiol Rev 2000;80:1107–1213.
[PubMed]
13.
Persky AM, Brazeau GA: Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev 2001;53:161–176.
[PubMed]
14.
Wyss M, Schulze A: Health implications of creatine: Can oral creatine supplementation protect against neurological and atherosclerotic disease? Neuroscience 2002;112:243–260.
15.
Kren S, Hostetter T: The course of the remnant kidney model in mice. Kidney Int 1999;56:333–337.
[PubMed]
16.
Taes YE, Delanghe JR, Wuyts B, Van De Voorde J, Lameire NH: Creatine supplementation does not affect kidney function in an animal model with pre-existing renal failure. Nephrol Dial Transplant 2003;18:258–264.
[PubMed]
17.
Thomason DB, Baldwin KM, Herrick RE: Myosin isoenzyme distribution in rodent hindlimb skeletal muscle. J Appl Physiol 1986;60:1923–1931.
[PubMed]
18.
Talmadge RJ, Roy RR: Electrophoretic separation of rat skeletal muscle myosin-heavy chain isoforms. J Appl Physiol 1993;75:2337–2340.
[PubMed]
19.
Delanghe J, De Slypere JP, De Buyzere M, Robbrecht J, Wieme R, Vermeulen A: Normal reference values for creatine, creatinine, and carnitine are lower in vegetarians. Clin Chem 1989;35:1802–1803.
[PubMed]
20.
Berlet HH: Comparative study of various methods for the extraction of free creatine and phosphocreatine from mouse skeletal muscle. Anal Biochem 1974;60:347–357.
[PubMed]
21.
Adams GR, Haddad F, McCue SA, Bodell PW, Zeng M, Qin L, Baldwin KM: Effects of spaceflight and thyroid deficiency on rat hindlimb development. II. Expression of MHC isoforms. J Appl Physiol 2000;88:904–916.
[PubMed]
22.
Saitoh A, Okumoto T, Nakano H, Wada M, Katsuta S: Age effects on expression of myosin heavy chain and light chain isoforms in suspended rat soleus muscle. J Appl Physiol 1999;86:1483–1489.
[PubMed]
23.
Diffee GM, Kalfas K, Al-Majid S, McCarthy DO: Altered expression of skeletal muscle myosin isoforms in cancer cachexia. Am J Physiol Cell Physiol 2002;283:C1376–C1382.
24.
Spangenburg EE, Talmadge RJ, Musch TI, Pfeifer PC, McAllister RM, Williams JH: Changes in skeletal muscle myosin heavy chain isoform content during congestive heart failure. Eur J Appl Physiol 2002;87:182–186.
[PubMed]
25.
Diesel W, Emms M, Knight BK, Noakes TD, Swanepoel CR, van Zyl Smit R, Kaschula RO, Sinclair-Smith CC: Morphologic features of the myopathy associated with chronic renal failure. Am J Kidney Dis 1993;22:677–684.
[PubMed]
26.
Ahonen RE: Light microscopic study of striated muscle in uremia. Acta Neuropathol 1980;49:51–55.
[PubMed]
27.
Haddad F, Qin AX, Zeng M, McCue SA, Baldwin KM: Effects of isometric training on skeletal myosin heavy chain expression. J Appl Physiol 1998;84:2036–2041.
[PubMed]
28.
Willoughby DS, Rosene J: Effects of creatine and resistance training on myosin heavy chain expression. Med Sci Sports Exerc 2001;33:1674–1681.
[PubMed]
29.
Stevens L, Firinga C, Gohlsch B, Bastide B, Mounier Y, Pette D: Effects of unweighting and clenbuterol on myosin light and heavy chains in fast and slow muscles of rat. Am J Physiol Cell Physiol 2000;279:C1558–C1563.
30.
Romanul FC, Van der Meulen JP: Reversal of the enzyme profiles in fast and slow muscles by cross innervation. Nature 1966;212:369–1371.
[PubMed]
31.
Pirzada NA, Morgenlander JC: Peripheral neuropathy in patients with chronic renal failure. A treatable source of discomfort and disability. Postgrad Med 1997;102:249–261.
[PubMed]
32.
Patten M, Kramer E, Bunemann J, Wenck C, Thoenes M, Wieland T, Long C: Endotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo. Pflügers Arch 2001;442:920–927.
[PubMed]
33.
Lawler JM, Barnes WS, Wu G, Song W, Demaree S: Direct antioxidant properties of creatine. Biochem Biophys Res Commun 2002;290:47–52.
[PubMed]
34.
Nomura A, Zhang M, Sakamoto T, Ishii Y, Morishima Y, Mochizuki M, Kimura T, Uchida Y, Sekizawa K: Anti-inflammatory activity of creatine supplementation in endothelial cells in vitro. Br J Pharmacol 2003;139:715–720.
[PubMed]
You do not currently have access to this content.